An Indian IT firm, Thalamus Irwine, has claimed to have developed a solution that can assist the government to identify vulnerable communities among the population whose immunization would put brakes on the spread of the COVID-19 infection. The company has named its Artificial Intelligence (AI) and Internet of Things (IoT)-based serosurvey platform named Garuda.
Where the governments generally take months to conduct a sero-study with thousands of samples, the company claims it could conduct a seroprevalence study of one crore samples within a week’s time.
Rishabh Sharma, CEO of the firm told IANS that he is also in talks with several state governments to implement his technology in their respective states. “While I’m not at liberty to disclose the names currently, what I can tell you is that a few states from North India and one from South India are considering the project,” he shared.
Sharma claimed that his…